Parkinson’s disease is the second most common incurable neurodegenerative disorder after Alzheimer’s disease.
It is characterised by the accumulation of protein deposits in dopaminergic neurons (in charge of producing dopamine) in the form of amyloid fibres. These aggregates are formed mainly by the alpha-synuclein protein and in a very complex manner, which makes it complicated to identify molecules which could prevent or revert the process and the neurodegeneration associated with it.
A scientific collaboration led by researchers at the Institute of Biotechnology and Biomedicine (IBB) of the Universitat Autònoma de Barcelona has identified a molecule which halts and reverts this neurodegeneration. After analysing over 14,000 molecules, they found the SynuClean-D molecule, which inhibits the aggregation of the alpha-synuclein protein and breaks the already formed amyloid fibres, thus preventing the initiation of the process causing the onset of the neurodegenerative Parkinson’s disease.
Through experiments conducted with the small Caenorhabditis elegans worm, one of the most commonly used animal models in neurodegenerative diseases, researchers were able to verify that by administering it through food, the molecule was capable of notably reducing alpha-synuclein aggregations, preventing the spread of toxic aggregates and therefore avoiding the degeneration of dopaminergic neurons.
“Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative disases such as Parkinson’s in the future”, UAB researcher and coordinator of the study Salvador Ventura points out.
To identify SynuClean-D researchers developed a methodology capable of indentifying the alpha-synuclein aggregation inhibitors among thousands of molecules. Once identified, an in vitro biophysical characterisation was conducted of their inhibiting activity and tests were run to discover their behaviour with human neural cell cultures, before testing it in animal models of the disease (the Caenorhabditis elegans worm). These animals express the alpha-synuclein in the muscle or in dopaminergic neurons. The experiments demonstrated that the administration of the identified inhibitor reduced protein aggregation, improving the mobility of the animal and protecting it from neural degeneration.
The Latest on: Parkinson’s
via Google News
The Latest on: Parkinson’s
- Mark and Stacy Parkinson create new scholarship to help DACA students succeed on February 18, 2019 at 7:52 am
The Parkinsons said they believe the contributions of immigrants have helped the United States become the greatest country in the world. “What we have built in the United States is a miracle,” Mark Pa... […]
- Parkinsons Disease Drugs And Therapeutics Market|Healthy Growth in 2019 Annual Results on February 17, 2019 at 9:33 pm
Parkinson’s disease is a chronic and progressive neurological disorder where the symptoms continue and worsen with time. The primary symptoms include tremor, slow movements, rigidity, and balance diff... […]
- Global Neurostimulation Devices Market Business Overview, Challenges, Opportunities, Trends and Market Analysis by 2028 on February 14, 2019 at 12:02 am
By application, the market is divided into Pain Management, Parkinsons Disease, Urinary and Fecal Incontinence, Epilepsy, Gastroparesis. Based on geography, a market is analyzed across North America, ... […]
- Parkinsons exercise group appeals for funding on February 13, 2019 at 3:24 am
The Diss and Eye Parkinsons support group began in 2017, growing from five to 20 couples over 18 months. Exercise plays an important role in helping to keep a Parkinsons sufferer mobile and maintain t... […]
- Honda receives grant for research on Walking Assist Device and Parkinsons’ Disease on February 11, 2019 at 12:00 am
Honda R&D Americas, Inc. and The Ohio State University have been awarded a grant by The Michael J. Fox Foundation (MJFF) to research the safety and potential positive impact that Honda’s Walking Assis... […]
- Primary school and Rotary Club give funding boost to help fight Parkinsons disease on February 9, 2019 at 7:12 am
TOTTINGTON and Bury West Rotary Club has received a welcome boost to their funds to fight Parkinsons disease thanks to some kind-hearted primary school pupils and parents. St Stephen's CofE Primary Sc... […]
- Global Parkinsons Disease Drugs and Therapeutics Market Insight Market Dynamics on Volume, Revenue, Size and Share Forecast Period 2017-2026 on December 18, 2018 at 7:59 pm
New York, NY -- (SBWIRE) -- 12/18/2018 -- A report on Parkinsons Disease Drugs and Therapeutics begins with a deep introduction of the global Parkinsons Disease Drugs and Therapeutics market and then ... […]
- The Fantastic Four – Another great visit with Mackay Parkinsons Support Group on October 18, 2018 at 8:26 am
This is the (fantastic) fourth occasion that I have been lucky enough to have been invited to speak with members of the Mackay Parkinsons Support group at the North Mackay Bowls Club. We are all start... […]
- How do you keep your camera steady? on September 12, 2018 at 5:00 pm
This is the first thing to consider I think for Parkinsons Photographers. Our group in Adelaide has explored this but what are some of the tips from other photographers with Parkinsons. Posts of your ... […]
via Bing News